Name | Value |
---|---|
Revenues | 1,177.0K |
Cost of Revenue | 440.0K |
Gross Profit | 737.0K |
Operating Expense | 1,439.0K |
Operating I/L | -702.0K |
Other Income/Expense | -100.0K |
Interest Income | 0.0K |
Pretax | -802.0K |
Income Tax Expense | 11.0K |
Net Income/Loss | -813.0K |
NanoVibronix, Inc. specializes in noninvasive biological response-activating devices for biofilm prevention, wound healing, and pain therapy. Its products include UroShield, an ultrasound-based solution for preventing bacterial colonization in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology for pain treatment; and WoundShield, a patch-based therapeutic ultrasound device for tissue regeneration and wound healing. The company generates revenue by selling its products directly to patients and through distributor agreements in the United States, Israel, Europe, India, and internationally.